-
Mar 19, 2021, 15:39 PM
by
Full story
-
Mar 19, 2021, 15:39 PM
by
Bally Ribbon Mills Bringing Smart Textiles to Commercialization
Incorporating E-WEBBINGS® e-textile product base into new designs
Full story
-
Mar 19, 2021, 15:39 PM
by
Full story
-
Mar 19, 2021, 15:39 PM
by
ComputaBio, a US based supplier of full-range computational biology services, has launched virtual screening service to assist drug design.
Full story
-
Mar 19, 2021, 15:39 PM
by
Watson-Marlow Fluid Technology Group (WMFTG) announces the launch of its upgraded website. The new website will reflect its sectorised sales strategy and future proof for upcoming global expansion plans to support more essential industries including biopharmaceutical, medical technology, water, food and waste.
Full story
-
Mar 19, 2021, 15:39 PM
by
Lyniate, a global leader in healthcare data interoperability, today announced new partnerships with two healthcare technology innovators: clinical exchange technology provider Secure Exchange Solutions (SES) and healthcare cybersecurity firm Sensato.
Full story
-
Mar 19, 2021, 15:39 PM
by
TrialAssure® – a leading, global software company advancing clinical trial disclosure, data sharing, and transparency – has announced today that Certara (Nasdaq: CERT) – the global leader in biosimulation – has licensed TrialAssure’s ANONYMIZE software to anonymize clinical data.
Full story
-
Mar 19, 2021, 15:39 PM
by
Future Planet Capital has invested in a $168m Series B financing announced today by Vaccitech Ltd.
Full story
-
Mar 19, 2021, 15:39 PM
by
Full story
-
Mar 19, 2021, 15:39 PM
by
Full story
-
Mar 19, 2021, 15:39 PM
by
Full story
-
Mar 19, 2021, 15:39 PM
by
THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), today announced the launch of new telehealth features. Building on four years of conducting electronic clinical outcome assessments (eCOA) during telehealth virtual visits, the new features raise the bar in DCT telehealth functionality by adding several unique enhancements to the company’s industry-leading eCOA and telehealth virtual visit solution. New features allow clinical study stakeholders – including sponsors, caregivers, home health professionals and raters – to remotely and safely capture video and/or audio recordings in real time.
Full story
-
Mar 19, 2021, 15:39 PM
by
Full story
-
Mar 19, 2021, 15:39 PM
by
Notes to editors
Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. RDIF has established joint strategic partnerships with leading international co-investors from over 18 countries attracting over $40 bn of capital. Further information can be found at rdif.ru
For more information about the Sputnik vaccine please visit sputnikvaccine.com/
Stelis Biopharma Pvt. Ltd. (Stelis) is a vertically integrated biopharmaceutical company. Stelis offers end-to-end state-of-the-art CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. Its operations include R&D, process development, scale-up & end-to-end cGMP manufacturing capabilities from drug substance through drug product in all formats and packaging. Stelis is also developing select follow-on biologic products for global markets in niche and commercially attractive disease categories. Stelis has recently forayed into Vaccine manufacturing with a capability to do multiple vaccine types. Stelis’ state-of-the-art research & development facility and 200,000 sq. ft. fully integrated cGMP manufacturing facility are located in Bengaluru, India. Facilities cater to the development and cGMP manufacturing of biologics and injectables conforming to international standards. For more information visit www.stelis.com
Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the United States (Florida). The Company focusses on “difficult to manufacture” products that are sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com
Full story
-
Mar 19, 2021, 15:39 PM
by
As the company celebrates its 10th anniversary this year, it is pleased to announce a strong 2020, reporting 1 Trillion won in sales!
Full story
-
Mar 19, 2021, 15:39 PM
by
Full story
-
Mar 18, 2021, 17:12 PM
by
User Not Found
Bio-IT World | Illumina has announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting on May 26, 2021.
Full story
-
Mar 18, 2021, 01:00 AM
by
User Not Found
Bio-IT World | The unprecedented accomplishment that is Moderna’s innovative mRNA Covid-19 vaccine proves—among other things—that a shift has come to life sciences. It’s time to bet on the underdog.
Full story
-
Mar 17, 2021, 01:00 AM
by
User Not Found
Bio-IT World | For well over a decade now, scientists have been experimenting with “couch potato” drugs that could confer the benefits of exercise without having to flex a muscle. The latest candidate is a small molecule inhibitor impeding the degradation of prostaglandin E2 (PGE2), recently shown to act directly on mature muscle fibers to prevent deleterious molecular changes that arise with aging.
Full story
-
Mar 15, 2021, 14:09 PM
by
User Not Found
Bio-IT World | Researchers at the University of Sussex have figured out a way to give desktop PCs the same horsepower as supercomputers, which could help democratize research involving large-scale brain simulations.
Full story